{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:11:18Z","timestamp":1791925878563,"version":"4.3.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T00:00:00Z","timestamp":1376438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00198-013-2469-4","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T14:48:23Z","timestamp":1376405303000},"page":"757-762","source":"Crossref","is-referenced-by-count":58,"title":["Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate"],"prefix":"10.1007","volume":"25","author":[{"given":"B.","family":"Abrahamsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. L.","family":"Grove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,14]]},"reference":[{"key":"2469_CR1","unstructured":"EMA (2013) Recommendation to restrict the use of Protelos \/ Osseor (strontium ranelate). http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2013\/04\/WC500142507.pdf Accessed 15 June 2013"},{"issue":"7","key":"2469_CR2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2165\/11533770-000000000-00000","volume":"33","author":"V Osborne","year":"2010","unstructured":"Osborne V, Layton D, Perrio M, Wilton L, Shakir SAW, Saad AW (2010) Incidence of venous thromboembolism in users of strontium ranelate: an analysis of data from a prescription-event monitoring study in England. Drug Saf Int J Med Toxicol Drug Experience 33(7):579\u2013591","journal-title":"Drug Saf Int J Med Toxicol Drug Experience"},{"key":"2469_CR3","doi-asserted-by":"crossref","unstructured":"Ulger Z, Gurel EI, Halil M, Oozen G, Kalan I, Seringec N et al. (2012) Hemorheological changes with strontium ranelate treatment do not seem to be related to its claimed prothrombotic effects. Arch Gerontol Geriatr 54(1):218\u2013221","DOI":"10.1016\/j.archger.2010.11.024"},{"issue":"3","key":"2469_CR4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jbmr.1783","volume":"28","author":"M Pazianas","year":"2012","unstructured":"Pazianas M, Clark EM, Eiken P a, Brixen K, Abrahamsen B (2012) Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications\u2014cohort analysis using a national prescription database. Journal of bone and mineral research. Off J Am Soc Bone Miner Res 28(3):455\u2013463","journal-title":"Off J Am Soc Bone Miner Res"},{"key":"2469_CR5","doi-asserted-by":"crossref","unstructured":"Musette P, Brandi ML, Cacoub P, Kaufman JM, Rizzoli R, Reginster JY (2009) Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity. Osteoporos Int 21(5):723\u201332. doi: 10.1007\/s00198-009-1097-5","DOI":"10.1007\/s00198-009-1097-5"},{"issue":"2","key":"2469_CR6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0895-4356(02)00591-7","volume":"56","author":"M Madsen","year":"2003","unstructured":"Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M (2003) The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 56(2):124\u2013130","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"2469_CR7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000102143","volume":"28","author":"LH Krarup","year":"2007","unstructured":"Krarup LH, Boysen G, Janjua H, Prescott E, Truelsen T (2007) Validity of stroke diagnoses in a National Register of Patients. Neuroepidemiology 28(3):150\u2013154","journal-title":"Neuroepidemiology"},{"key":"2469_CR8","doi-asserted-by":"crossref","unstructured":"Bondo L, Eiken P, Abrahamsen B (2013) Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients\u2014a nationwide register-based open cohort study. Osteoporos Int. 24(1):245-52. doi: 10.1007\/s00198-012-2024-8","DOI":"10.1007\/s00198-012-2024-8"},{"issue":"3","key":"2469_CR9","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2009-0852","volume":"95","author":"MJ Bolland","year":"2010","unstructured":"Bolland MJ, Grey AB, Gamble GD, Reid IR (2010) Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrinol Metab 95(3):1174\u20131181","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2469_CR10","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/jbmr.1792","volume":"28","author":"F Wolfe","year":"2013","unstructured":"Wolfe F, Bolster MB, O'Connor CM, Michaud K, Lyles KW, Col\u00f3n-Emeric CS (2013) Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis. JBMR 28(5):984\u2013991","journal-title":"JBMR"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2469-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-013-2469-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2469-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:08:55Z","timestamp":1558624135000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-013-2469-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,14]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["2469"],"URL":"https:\/\/doi.org\/10.1007\/s00198-013-2469-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,14]]}}}